scholarly journals Long-term Outcome of Coronary Abnormalities in Kawasaki Disease

2003 ◽  
Vol 53 (1) ◽  
pp. 186-186
Author(s):  
Hiroshi Nishikawa ◽  
Masaki Matsushima ◽  
Naoki Oohashi ◽  
Namiko Kojima ◽  
Masami Nagashima
Keyword(s):  
Kawasaki Disease ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Coronary Abnormalities

Long-Term Outcome of Coronary Abnormalities in Patients After Kawasaki Disease

1996 ◽  
Vol 17 (2) ◽  
pp. 71-76
Author(s):  
J. Fukushige ◽  
N. Takahashi ◽  
K. Ueda ◽  
T. Hijii ◽  
H. Igarashi ◽  
...  
Keyword(s):  
Kawasaki Disease ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Coronary Abnormalities

Long-term outcome of coronary abnormalities in patients after Kawasaki disease

1996 ◽  
Vol 17 (2) ◽  
pp. 71-76 ◽  
Author(s):  
J. Fukushige ◽  
N. Takahashi ◽  
K. Ueda ◽  
T. Hijii ◽  
H. Igarashi ◽  
...  
Keyword(s):  
Kawasaki Disease ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Coronary Abnormalities

scholarly journals Long-term Outcome of Patients with Kawasaki Disease

2003 ◽  
Vol 53 (1) ◽  
pp. 185-185
Author(s):  
Kenji Waki ◽  
Kiyoshi Baba ◽  
Yoshio Arakaki ◽  
Shin-Ichiro Yoshimura
Keyword(s):  
Kawasaki Disease ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany

Healthcare ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 481
Author(s):  
Götz Wehl ◽  
Jörg Franke ◽  
Martin Frühwirth ◽  
Michael Edlinger ◽  
Markus Rauchenzauner
Keyword(s):  
Kawasaki Disease ◽  
Controlled Trial ◽  
High Dose ◽  
Toxic Shock ◽  
Good Tolerability ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Immune Mediated ◽  
Cardiac Manifestations

Pediatric inflammatory multisystem syndrome temporally associated with SARS Cov2 (PIMS-TS) is a newly encountered disease in children sharing clinical features with Kawasaki disease, toxic shock syndrome, or macrophage-activating syndrome. Pathogenically, it is associated with immune-mediated post-infectious hyperinflammation leading to short-term myocardial injury with yet unknown long-term outcome. We herein present three cases of PIMS-TS treated in our institution with divided doses of immunoglobulins and high dose acetyl salicylic acid, according to existing Kawasaki disease guidelines. Due to greater weight in adolescents affected and concerns of rheological sequelae following possible hyperviscosity, doses of immunoglobulins were divided and given 24 h apart with good tolerability. All patients recovered rapidly with normalization of previously encountered cardiac manifestations. As diagnosis of PIMS-TS should be made promptly, timing of therapy is of paramount importance for a favorable outcome. To date, no randomized controlled trial data exist concerning treatment recommendations. 1.8% (95% CI: 1.7% to 2.0%) of all children and adolescents in the county district of Ostallgäu were tested positive for SARS CoV-2, incidence of PIMS-TS was 1.7% (95% CI: 0.9% to 3.1%) among SARS CoV-2 positive tested earlier. As the pandemic is still ongoing, rising numbers of PIMS-TS in children might be expected.

scholarly journals Long-Term Outcome of Kawasaki Disease

Circulation ◽  
2008 ◽  
Vol 118 (25) ◽  
pp. 2763-2772 ◽  
Author(s):  
Hideaki Senzaki
Keyword(s):  
Kawasaki Disease ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-term outcome of coronary artery dilatation in Kawasaki disease

2018 ◽  
Vol 11 (2) ◽  
pp. 125 ◽  
Author(s):  
Najib Advani ◽  
Sudigdo Sastroasmoro ◽  
Teddy Ontoseno ◽  
CunoSPM Uiterwaal
Keyword(s):  
Coronary Artery ◽  
Kawasaki Disease ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Coronary Artery Dilatation
Sign in / Sign up

Export Citation Format

Share Document